secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagonist Therapeutics, Inc (PTGX)
CIK:        0001377121
Form:       8-K
Filed at:   2025-06-26T23:59:59+00:00
Accession:  0001104659-25-063038
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Protagonist Therapeutics shareholders elect directors, approve say-on-pay, ratify auditor
--------------------------------------------------------------------------------

- Harold Selick and Bryan Giraudo elected Class III directors with ~83% and ~79% of votes cast, respectively.
- Non-binding advisory vote on executive compensation approved: 50.8M for, 2.9M against, 0.3M abstentions.
- Ratification of Ernst & Young as independent auditor for FY 2025 approved: 55.5M for, 74k against, 0.4M abstentions.
- No other proposals were submitted; broker non-votes were 1,918,517 for all director and say-on-pay items.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1377121/000110465925063038/0001104659-25-063038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1377121/000110465925063038/tm2518863d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-063038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer